Drugs.com

JUNE 14, 2024

FRIDAY, June 14, 2024 -- COVID vaccine makers will be advised to update their shots to target the KP.2 Food and Drug Administration announced Thursday. 2 variant, an offshoot of the JN.1 1 variant that spread widely last winter, the U.S.

Vaccine 289

Vaccine FDA Drugs 289

Drugs.com

JUNE 6, 2024

Food and Drug Administration advisory panel on Wednesday recommended updating the formula for COVID vaccines ahead of a fall campaign that will encourage Americans to get the latest shots.The unanimous vote. THURSDAY, June 6, 2024 -- A U.S.

Vaccine 264

Vaccine FDA Drugs 264

Drugs.com

APRIL 8, 2024

MONDAY, April 8, 2024 (HealthDay news) -- A new vaccine might be able to block the toxic effects of the animal tranquilizer xylazine, which is being added to illicit drugs and increasing overdose risk.The vaccine trains the immune system to attack.

Vaccine 244

Vaccine Drugs 244

Drugs.com

SEPTEMBER 20, 2024

Food and Drug Administration on Friday approved FluMist nasal spray as the first influenza vaccine that can be. FRIDAY, Sept. 20, 2024 -- The days of waiting for a flu shot at your doctor's office or local pharmacy may be over: The U.S.

FDA Approval 279

FDA Approval Vaccine Pharmacy Doctors 279

Drugs.com

SEPTEMBER 4, 2024

4, 2024 -- Current vaccines against mpox were designed to fight an older, rarer cousin of the virus, smallpox.Now, new research from the drug company Moderna suggests its new mpox vaccine, based on mRNA technology, might do a. WEDNESDAY, Sept.

Vaccine 246

Vaccine Trials Virus Research 246

Drugs.com

OCTOBER 26, 2024

Food and Drug Administration has approved the at-home use of the flu vaccine spray FluMist, how do you know that it's the right choice for you and your family?One SATURDAY, Oct. 26, 2024 -- Now that the U.S. One expert offers advice on the spray's.

Vaccine 264

Vaccine Drugs 264

Drugs.com

JUNE 10, 2024

Food and Drug Administration on Friday has for the first time approved the use of a respiratory syncytial virus (RSV) vaccine for people in their 50s who are at increased risk for the illness. MONDAY, June 10, 2024 -- The U.S. Drugmaker GSK's.

Vaccine 264

Vaccine Virus FDA Drugs 264

Drugs.com

NOVEMBER 10, 2023

10, 2023 (Healthday News) -- The first vaccine to prevent infection with the chikungunya virus was approved by the U.S. Food and Drug Administration on Thursday. FRIDAY, Nov. The single-dose shot, known as Ixchiq, is approved for adults who are at.

Virus 264

Virus FDA Approval Vaccine FDA 264

Drugs.com

JUNE 10, 2024

Food and Drug Administration on Friday has for the first time approved the use of a respiratory syncytial virus (RSV) vaccine for people in their 50s who are at increased risk for the illness. MONDAY, June 10, 2024 -- The U.S. Drugmaker GSK's.

Vaccine 246

Vaccine Virus FDA Drugs 246

Drugs.com

SEPTEMBER 22, 2023

22, 2023 -- Women may soon have a vaccine they can take during a pregnancy to help protect their newborn from respiratory syncytial virus (RSV). Food and Drug Administration, the Centers for. FRIDAY, Sept. Following approval one month ago by the U.S.

Vaccine 214

Vaccine Virus Drugs 214

Drugs.com

AUGUST 22, 2023

22, 2023 -- Women may soon have a vaccine they can take during a pregnancy to help protect their newborn from respiratory syncytial virus (RSV), following U.S. Food and Drug Administration approval of the shot, called Abrysvo, on. TUESDAY, Aug.

FDA Approval 189

FDA Approval Vaccine Virus FDA 189

Drugs.com

AUGUST 22, 2023

22, 2023 -- Women may soon have a vaccine they can take during a pregnancy to help protect their newborn from respiratory syncytial virus (RSV), following U.S. Food and Drug Administration approval of the shot, called Abrysvo, on. TUESDAY, Aug.

Vaccine 189

Vaccine FDA Approval Virus FDA 189

Drugs.com

FEBRUARY 18, 2025

Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active immunization against invasive meningococcal disease (IMD), according to a press release from. TUESDAY, Feb. 18, 2025 -- The U.S.

FDA Approval 147

FDA Approval Vaccine FDA Disease 147

Drugs.com

JUNE 9, 2023

Food and Drug Administration advisory panel on Thursday recommended that the agency approve an RSV vaccine for infants and some toddlers. FRIDAY, June 9, 2023 – A U.S. The monoclonal antibody shot would protect against respiratory syncytial.

Vaccine 147

Vaccine FDA Drugs 147

Drugs.com

JUNE 9, 2023

Food and Drug Administration advisory panel on Thursday recommended that the agency approve an RSV vaccine for infants and some toddlers. FRIDAY, June 9, 2023 – A U.S. The monoclonal antibody shot would protect against respiratory syncytial virus.

Vaccine 130

Vaccine FDA Virus Drugs 130

Drugs.com

SEPTEMBER 11, 2023

Food and Drug Administration took action approving and authorizing for emergency use updated COVID-19 vaccines formulated to more closely target currently circulating variants and to provide better protection. September 11, 2023 -- Today, the U.S.

Vaccine 130

Vaccine FDA Drugs 130

PPD

JUNE 24, 2024

In the realm of vaccine development, mega trials — studies enrolling 5,000 subjects or more — have been instrumental in the fight against many pathogens, including influenza, rotavirus, malaria, RSV and most recently in the rapid development of vaccines against COVID-19.

Vaccine 97

Vaccine Trials Clinical Trials Laboratories 97

DrugBank

MARCH 12, 2025

The COVID-19 pandemic brought mRNA to global prominence by developing highly effective vaccines by Moderna and Pfizer-BioNTech. Unlike traditional therapeutic approaches, which often involve chemically synthesized drugs or biologics, mRNA leverages the body’s cellular machinery to produce its therapeutic proteins.

Vaccine 97

Vaccine Treatment Clinical Trials Therapies 97

SCIENMAG: Medicine & Health

AUGUST 8, 2023

PHILADELPHIA – A new study finds that people are more likely to recommend that a pregnant family member or friend get vaccinated to protect the infant from RSV illness if they are shown a chart outlining the rigorous process a vaccine undergoes to be approved by the Food and Drug Administration (FDA).

Vaccine 88

Vaccine FDA Drugs Science 88

ASPET

AUGUST 3, 2023

Mechanistic modeling can be used to describe the time course of vaccine-induced humoral immunity and to identify key biological drivers in antibody production. We utilized a six-compartment mechanistic model to describe a 20-week time course of humoral immune responses in 56 non-human primates (NHPs) elicited by vaccination with Ad26.COV2.S

Vaccine 100

Vaccine Immune Response Production Drugs 100

The Pharma Data

AUGUST 14, 2020

Professor Alexander Chuchalin has quit the Russian Health Ministry’s ethics council due to the quick approval process for the country’s coronavirus vaccine. Many countries have criticised Russia pursuit for a COVID-19 cure, which has skipped Phase 3 trials before giving the vaccine regulatory approval. Safety always comes first.

Vaccine 87

Vaccine Doctors Clinical Trials Trials 87

National Drug & Alcohol Research Centre Blog

FEBRUARY 24, 2022

Olivia Price It has been one year since the COVID-19 vaccine rollout commenced in Australia, and while vaccination rates initially lagged behind other countries, over 95% of Australians aged 12 years and older are now fully vaccinated. We tend to consider the remaining unvaccinated people a homogenous ‘anti-vax’ group.

Vaccine 52

Vaccine Drugs Disease Pharmaceuticals 52

Tebu Bio: Drug Discovery

APRIL 24, 2020

mRNA vaccines are developing very quickly with dozens of ongoing clinical trials against cancers or infectious diseases (e.g. Nevertheless, researchers are now considering using messenger RNA (mRNA) technologies for the development of prophylactic and therapeutic vaccines. HIV or more recently SARS-Cov-2).

Vaccine 52

Vaccine Clinical Trials RNA Trials 52

The Pharma Data

AUGUST 17, 2020

The Chinese Centre for Drug Evaluation (CCDE) has said that coronavirus vaccines must show 50 percent efficacy to be approved. . The CCDE also said companies would have to prove their vaccines could provide immunity from the virus for a minimum of six months and be effective for 70 percent of the population. . Conor Kavanagh.

Vaccine 52

Vaccine Regulations Virus Clinical Trials 52

Tebu Bio: Drug Discovery

SEPTEMBER 23, 2021

Propelled into the spotlight by the COVID-19 pandemic, mRNA has become a biological entity of great interest in drug discovery - yet mRNA vaccination is just the beginning of more and more discoveries and applications.

Vaccine 52

Vaccine Drugs 52

The Pharma Data

JUNE 24, 2021

The primary objective in the trial is to describe safety when both vaccines are co-administered, with follow up six months after vaccination. Secondary objectives are to describe immune responses produced by each of the vaccines. Secondary objectives are to describe immune responses produced by each of the vaccines.

Vaccine 52

Vaccine Immune Response FDA Licensing 52

The Pharma Data

DECEMBER 11, 2020

Marshals to Protect COVID-19 Vaccines. 11, 2020 — COVID-19 vaccines will be protected by U.S. Food and Drug Administration is expected to quickly give emergency authorization to the Pfizer COVID-19 vaccine, which would be followed by an undertaking to distribute 3 million doses of the vaccine nationwide, CBS News reported.

Vaccine 52

Vaccine Drugs 52

PPD

MAY 11, 2023

The global COVID-19 pandemic increased awareness of the importance of vaccine development — both for drug developers and the public. The speed at which COVID-19 vaccines were developed was remarkable, but like most newly developed vaccines, there was variation among who could receive the shots and when.

Vaccine 52

Vaccine Clinical Trials Long-Term Care Facilities Trials 52

The Pharma Data

OCTOBER 22, 2020

COVID-19 Vaccine Trial Enrolls 30,000. 22, 2020 — The first company to start a phase 3 trial of a COVID-19 vaccine reached its target of enrolling 30,000 participants, CNN reported Thursday. Half of the participants were given the vaccine and half received a placebo. That would show the vaccine is 75 percent effective.

Vaccine 52

Vaccine Trials FDA Marketing 52

The Pharma Data

APRIL 14, 2021

We are aware of an extremely rare disorder involving people with blood clots in combination with low platelets in a small number of individuals who have received our COVID-19 vaccine. The United States Centers for Disease Control (CDC) and Food and Drug Administration (FDA) are reviewing data involving six reported U.S.

Vaccine 52

Vaccine Clinical Trials FDA Trials 52

The Pharma Data

DECEMBER 22, 2020

22, 2020 — In very rare cases, some people have had severe allergic reactions after receiving the new COVID-19 vaccines, leading the American College of Allergy , Asthma, and Immunology (ACAAI) to issue updated guidance for Americans with allergies. TUESDAY, Dec. per 1 million doses given to patients, according to the ACAAI.

Vaccine 52

Vaccine Immune Response Treatment Disease 52

The Pharma Data

DECEMBER 17, 2020

Advisory Committee Votes to Recommend EUA for Moderna Vaccine. 17, 2020 — The Moderna COVID-19 vaccine received recommendation from a U.S. Food and Drug Administration advisory committee on Thursday, clearing the way for it to become the second COVID-19 vaccine to be granted emergency use authorization.

Vaccine 52

Vaccine Clinical Trials Government FDA 52

The Pharma Data

MAY 3, 2021

The European Medicines Agency (EMA) is evaluating an application submitted by Pfizer and BioNTech for use of their COVID-19 vaccine in children aged 12 to 15 years. . The vaccine has been authorized by the EU for use in people 16 years and up since December 2020. . Pfizer also shared antibody responses from the younger age group.

Vaccine 52

Vaccine RNA Clinical Trials Packaging 52

The Pharma Data

DECEMBER 2, 2020

Britain Approves Emergency Use of Pfizer COVID-19 Vaccine. 2, 2020 — Britain became the first Western country to allow emergency use of a COVID-19 vaccine on Wednesday after approving the Pfizer vaccine candidate in the race to inoculate millions of people around the globe. WEDNESDAY, Dec. The New York Times Article.

Vaccine 52

Vaccine Long-Term Care Facilities Nurses Government 52

The Pharma Data

NOVEMBER 23, 2020

As the Pfizer-BioNTech COVID-19 vaccine is being evaluated by the U.S. Food and Drug Administration (FDA) and the Moderna vaccine is soon to follow, here’s a look at several of the top COVID-19 vaccine candidates and where they stand as of today. Like the Pfizer-BioNTech vaccine, it is an mRNA vaccine.

Vaccine 52

Vaccine Virus Immune Response Trials 52

The Pharma Data

MAY 4, 2021

The New Zealand Medicines and Medical Devices Safety Authority (Medsafe) has banned the trade in unapproved COVID-19 vaccines for a year to prevent the use of vaccines that may not be safe or effective. . The public could also import personal supplies of vaccines. Medsafe framed the action in the context of public safety. . “In

Vaccine 52

Vaccine FDA Licensing Licensing 52

The Pharma Data

JANUARY 22, 2021

As research developments into RNA vaccines help scientists accelerate drug candidates to arm the immune system against coronavirus, Pharma IQ ’s Keeping tabs on Covid-19 update returns with news from some of the biotechnology innovators leading the fight against the global pandemic.

Vaccine 52

Vaccine Immune Response Government RNA 52